Corimmun
Latest round
- Series A
Last raised
- Sep 2008
Total raised
- $7.9M
Investors
- 5
About Corimmun
Corimmun GmbH is a biotechnology company, develops therapeutics for the treatment of congestive heart failure and atherosclerosis.
Who invested in Corimmun
5 investors across 2 rounds
See all investors in Corimmun
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Corimmun
Who invested in Corimmun?
Corimmun has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Corimmun raised?
Corimmun has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Corimmun last raise money?
Corimmun's most recent round on record is a Series A, in Sep 2008.
What does Corimmun do?
Corimmun GmbH is a biotechnology company, develops therapeutics for the treatment of congestive heart failure and atherosclerosis.
Where is Corimmun headquartered?
Corimmun is headquartered in Germany.
Which VCs invest in companies like Corimmun?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Corimmun's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Corimmun? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.